Petal Surgical emerged from stealth with a $10M in Series A funding, bringing total capital raised to nearly $20M. The company is developing a robotic platform that performs incisionless surgery using focused ultrasound to destroy tumors through acoustic liquefaction, where high-intensity sound waves mechanically break down targeted tissue. The round was co-led by K50 Ventures and TSVC.
- Company
- Petal Surgical petalsurgical.com
- Round
- Series A
- Amount
- $10M
- Source
- massdevice.com
- In the newsletter
- No. 212, Street-Fighting Mathematics